Preclinical testing of a vaccine candidate against tularemia.
Tularemia is caused by a gram-negative, intracellular bacterial pathogen, Francisella tularensis (Ft). The history weaponization of Ft in the past has elevated concerns that it could be used as a bioweapon or an agent of bioterrorism. Since the discovery of Ft, three broad approaches adopted for tul...
Main Authors: | Ragavan Varadharajan Suresh, Zhuo Ma, Raju Sunagar, Vivek Bhatty, Sukalyani Banik, Sally V Catlett, Edmund J Gosselin, Meenakshi Malik, Chandra Shekhar Bakshi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4405390?pdf=render |
Similar Items
-
Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
by: Manish Mahawar, et al.
Published: (2013-01-01) -
Nlrp3 Increases the Host’s Susceptibility to Tularemia
by: Ragavan V. Suresh, et al.
Published: (2021-10-01) -
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection
by: Sudeep Kumar, et al.
Published: (2020-04-01) -
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
by: Sudeep Kumar, et al.
Published: (2019-05-01) -
Editorial: Candida auris - understanding the new superbug
by: Sukalyani Banik
Published: (2023-07-01)